{"nct_id":"NCT00316173","title":"Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer","status":"COMPLETED","status_verified_date":"2012-11","start_date":"2005-03","start_date_type":null,"primary_completion_date":"2009-01","primary_completion_date_type":"ACTUAL","completion_date":"2009-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}